Signet Healthcare Partners and Windham Capital Partners Lead Majority Recapitalization of PainTEQ

August 27, 2025

PainTEQ, a Tampa-based developer of minimally invasive sacroiliac (SI) joint implants, completed a majority growth recapitalization co-led by Signet Healthcare Partners and Windham Capital Partners with a new equity investment from MVolution Partners. The capital will fund clinical studies, next-generation product development and expansion of PainTEQ's U.S. commercial presence; transaction terms were not disclosed.

Buyers
Signet Healthcare Partners, Windham Capital Partners, MVolution Partners
Targets
PainTEQ
Industry
Medical Devices
Location
Florida, United States
Transaction Type
Recapitalization

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.